p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors

SJ Gallagher, JF Thompson, J Indsto, LL Scurr, M Lett… - Neoplasia, 2008 - Elsevier
Metastatic cutaneous melanoma is highly resistant to cytotoxic drugs, and this contributes to
poor prognosis. In vivo studies on the chemosensitivity of metastatic melanoma are rare and …
被引用次数：52 相关文章
[PDF] researchgate.net

[PDF][PDF] p16INK4a Expression and Absence of Activated B-RAF Are Independent Predictors of Chemosensitivity in Melanoma Tumors

Neoplasia, 2008 - researchgate.net
Metastatic cutaneous melanoma is highly resistant to cytotoxic drugs, and this contributes to
poor prognosis. In vivo studies on the chemosensitivity of metastatic melanoma are rare and …
[PDF] cyberleninka.org

[PDF][PDF] p16INK4a Expression and Absence of Activated B-RAF Are Independent Predictors of Chemosensitivity in Melanoma Tumors

Neoplasia, 2008 - cyberleninka.org
Metastatic cutaneous melanoma is highly resistant to cytotoxic drugs, and this contributes to
poor prognosis. In vivo studies on the chemosensitivity of metastatic melanoma are rare and …

p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors

SJ Gallagher, JF Thompson, J Indsto, LL Scurr… - …, 2008 - researchers.mq.edu.au
Metastatic cutaneous melanoma is highly resistant to cytotoxic drugs, and this contributes to
poor prognosis. In vivo studies on the chemosensitivity of metastatic melanoma are rare and …
[PDF] core.ac.uk

[PDF][PDF] p16INK4a Expression and Absence of Activated B-RAF Are Independent Predictors of Chemosensitivity in Melanoma Tumors

Neoplasia, 2008 - core.ac.uk
Metastatic cutaneous melanoma is highly resistant to cytotoxic drugs, and this contributes to
poor prognosis. In vivo studies on the chemosensitivity of metastatic melanoma are rare and …

p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors

SJ Gallagher, JF Thompson, J Indsto… - … (New York, NY), 2008 - pubmed.ncbi.nlm.nih.gov
Metastatic cutaneous melanoma is highly resistant to cytotoxic drugs, and this contributes to
poor prognosis. In vivo studies on the chemosensitivity of metastatic melanoma are rare and …

p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors.

SJ Gallagher, JF Thompson, J Indsto… - Neoplasia (New York …, 2008 - europepmc.org
Metastatic cutaneous melanoma is highly resistant to cytotoxic drugs, and this contributes to
poor prognosis. In vivo studies on the chemosensitivity of metastatic melanoma are rare and …
[PDF] academia.edu

[PDF][PDF] p16 INK4a Expression and Absence of Activated B-RAF Are Independent Predictors of Chemosensitivity in Melanoma Tumors

SJ Gallagher, JF Thompson - Neoplasia, 2008 - academia.edu
Metastatic cutaneous melanoma is highly resistant to cytotoxic drugs, and this contributes to
poor prognosis. In vivo studies on the chemosensitivity of metastatic melanoma are rare and …
[HTML] nih.gov

[HTML][HTML] p16INK4a Expression and Absence of Activated B-RAF Are Independent Predictors of Chemosensitivity in Melanoma Tumors

SJ Gallagher, JF Thompson, J Indsto… - … (New York, NY), 2008 - ncbi.nlm.nih.gov
Metastatic cutaneous melanoma is highly resistant to cytotoxic drugs, and this contributes to
poor prognosis. In vivo studies on the chemosensitivity of metastatic melanoma are rare and …
[PDF] academia.edu

[PDF][PDF] p16 INK4a Expression and Absence of Activated B-RAF Are Independent Predictors of Chemosensitivity in Melanoma Tumors

SJ Gallagher, JF Thompson - Neoplasia, 2008 - academia.edu
Metastatic cutaneous melanoma is highly resistant to cytotoxic drugs, and this contributes to
poor prognosis. In vivo studies on the chemosensitivity of metastatic melanoma are rare and …